Company: OSRH
Filing Date: 2025-01-29
Form Type: S-4/A
Source: 0001213900-25-007923
Chunk: 682

Company: OSR Holdings, Inc.
Filing Date: 2025-01-29
Form: S-4/A
Chunk 682
---
,262,488 |   |
| Effects of changes in exchange rate on cash and cash equivalents |     |       |     |           5,772,356 |   |     |      (1,370,850 | ) |
| Cash and cash equivalents at the beginning of the                
 year                                                             |     |       |     |         689,973,487 |   |     |     309,081,849 |   |
| Cash and cash equivalents at the end of the year                 |     |       |     | ₩       325,093,826 |   |     | ₩   689,973,487 |   |

The accompanying notes are an integral part of financial statements.

F-142

1. General information Darnatein Co., Ltd. (the “Company”) is a clinical -stagebiopharmaceutical company founded in 2012, established under the laws of the Republic of Korea, focused on developing and commercializing disease -modifyingosteoarthritis drug. As at December 31, 2022, the total outstanding ordinary shares amount to W6,447 million, and the majority shareholder of the Company is Joint Protein Central Ltd., which owns 34.02% (4,400,000shares) of the Company’s total outstanding ordinary shares. The company is headquartered at 30 Songdomirae -ro, Yeonsu -gu, Incheon. Details of the major shareholders as at December 31, 2022 and 2021 are as follows:

|                                 |     | Location |     | Percentage of ownership (%) 
                December 31, 
                        2022 |   |     | December 31, 
         2021 |   |     | Closing  
 month    |     | Main business   |
|:--------------------------------|:----|:---------|:----|----------------------------:|:--|:----|-------------:|:--|:----|:---------|:----|:----------------|
| Joint Protein Central Co., Ltd. |     | Korea    |     |                       34.02 | % |     |        35.99 | % |     | December |     | Pharmaceuticals |
| Crystal Bioscience Co., Ltd.    |     | Korea    |     |                       22.89 | % |     |        24.21 | % |     | December |     | Pharmaceuticals |
| Crystal Genomics Co., Ltd.      |     | Korea    |